{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:35Z","timestamp":1791112475895,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.atherosclerosis.2014.02.032","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T01:15:35Z","timestamp":1394846135000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia"],"prefix":"10.1016","volume":"234","author":[{"given":"Petra","family":"El Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanee","family":"Plengpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frisdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerapan","family":"Khovidhunkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib1","doi-asserted-by":"crossref","first-page":"23K","DOI":"10.1016\/S0002-9149(03)00779-3","article-title":"Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams","volume":"92","author":"Brewer","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib4","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.pgen.1002393","article-title":"Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol","volume":"7","author":"Khetarpal","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib6","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.CIR.101.16.1907","article-title":"Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene","volume":"101","author":"Agerholm-Larsen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.amjcard.2009.05.021","article-title":"Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men","volume":"104","author":"Okamura","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1194\/jlr.M400090-JLR200","article-title":"Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism","volume":"45","author":"Ruel","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a124516","article-title":"Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins","volume":"116","author":"Ishigami","year":"1994","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI27602","article-title":"HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway","volume":"116","author":"Matsuura","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2008.12.012","article-title":"Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients","volume":"402","author":"Miwa","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0022-2275(20)40055-0","article-title":"Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency","volume":"36","author":"Ohta","year":"1995","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/ATVBAHA.108.179416","article-title":"Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway","volume":"29","author":"Catalano","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/ATVBAHA.109.194548","article-title":"Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent","volume":"29","author":"Larrede","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2012.02.052","article-title":"Resequencing CETP, LIPC and LIPG genes in Thai subjects with hyperalphalipoproteinemia","volume":"110","author":"Khovidhunkit","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2011.01.051","article-title":"CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes","volume":"216","author":"Plengpanich","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2012.11.024","article-title":"Functional characterization of novel variants in the CETP promoter and the LIPC gene in subjects with hyperalphalipoproteinemia","volume":"416","author":"Plengpanich","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.16.6.763","article-title":"Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia","volume":"16","author":"Guerin","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib21","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.112.252841","article-title":"Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women","volume":"32","author":"Villard","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1194\/jlr.M500466-JLR200","article-title":"Measurement of cholesterol bidirectional flux between cells and lipoproteins","volume":"47","author":"Zimetti","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib23","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1016\/S0021-9258(18)34593-9","article-title":"Mechanism of cholesterol efflux from cells. Effects of acceptor structure and concentration","volume":"257","author":"Rothblat","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1194\/jlr.M500255-JLR200","article-title":"Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis","volume":"47","author":"Le Goff","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-2275(20)32462-7","article-title":"Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface","volume":"40","author":"de la Llera-Moya","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib27","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1522","article-title":"Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux","volume":"97","author":"Chan","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehr103","article-title":"Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein","volume":"33","author":"Hoang","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbalip.2006.12.004","article-title":"LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI\/Cla-1 receptor","volume":"1771","author":"Treguier","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib32","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1074\/jbc.M008725200","article-title":"Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI)","volume":"276","author":"Greene","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib33","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI118751","article-title":"Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels","volume":"97","author":"Zhong","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-2275(20)39912-0","article-title":"Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma","volume":"36","author":"Parks","year":"1995","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0005-2760(88)90168-3","article-title":"Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma","volume":"962","author":"Cheung","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib36","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1016\/S0021-9258(17)39427-9","article-title":"Activation of lecithin cholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids","volume":"260","author":"Zorich","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1194\/jlr.M300198-JLR200","article-title":"Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency","volume":"45","author":"Asztalos","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)33299-5","article-title":"Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein","volume":"39","author":"Rye","year":"1998","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib39","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.ATV.15.11.1819","article-title":"Triglycerides are major determinants of cholesterol esterification\/transfer and HDL remodeling in human plasma","volume":"15","author":"Murakami","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0026-0495(98)90352-3","article-title":"Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity","volume":"47","author":"Sich","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib41","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0022-2275(20)31525-X","article-title":"Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL","volume":"42","author":"de La Llera-Moya","year":"2001","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041433-200406000-00008","article-title":"Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids","volume":"15","author":"Connelly","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib44","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s00018-005-5194-0","article-title":"The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis","volume":"62","author":"Jacquet","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib45","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.23897","article-title":"P2Y13 receptor is critical for reverse cholesterol transport","volume":"52","author":"Fabre","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib46","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.102.18.2197","article-title":"Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: the Copenhagen City Heart Study","volume":"102","author":"Agerholm-Larsen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib47","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehm062","article-title":"High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides","volume":"28","author":"Borggreve","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1517\/14622416.2.1.S1","article-title":"Rationale and design of the LURIC study\u2013a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.109.875013","article-title":"Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study","volume":"121","author":"Ritsch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.02.032_bib50","first-page":"12248","article-title":"Ritsch a decreased cholesterol efflux capacity in patients with low CETP plasma levels","volume":"2014","author":"Scharnagl","year":"2014","journal-title":"Eur J Clin Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014001312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014001312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:06:43Z","timestamp":1648598803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014001312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0021915014001312"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.02.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}